Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC

BSE4842.40-97 (-1.96 %)

PREV CLOSE ( ) 4939.40

OPEN PRICE ( ) 4930.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 617

TODAY'S LOW / HIGH ( )4792.50 4959.90

52 WK LOW / HIGH ( )4727.9 6700

NSE4857.40-79.3 (-1.61 %)

PREV CLOSE( ) 4936.70

OPEN PRICE ( ) 4930.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 4857.40 (2)

VOLUME 12172

TODAY'S LOW / HIGH( ) 4801.00 4960.50

52 WK LOW / HIGH ( )4725 6739

Select year

(Rs.in Million)

Particulars

Mar 2025

Jun 2024

Jun 2023

Jun 2022

Jun 2021

Profit Before Tax

3116.20

2733.20

3142.00

2533.70

2332.80

Adjustment

122.00

522.70

414.90

273.10

408.90

Changes In working Capital

-738.10

-121.20

-300.20

-473.00

412.20

Cash Flow after changes in Working Capital

2500.10

3134.70

3256.70

2333.80

3153.90

Cash Flow from Operating Activities

1686.90

2282.90

2360.10

1695.20

2472.60

Cash Flow from Investing Activities

95.90

-68.70

-215.00

-255.40

-322.70

Cash Flow from Financing Activities

-2347.40

-4181.10

-984.70

-2886.30

-3866.30

Net Cash Inflow / Outflow

-564.60

-1966.90

1160.40

-1446.50

-1716.40

Opening Cash & Cash Equivalents

2387.30

4354.20

3194.00

4640.50

6356.90

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

1822.70

2387.30

4354.40

3194.00

4640.50